Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD 176.42
-2.97 (-1.66%)
Sep 1, 2026, 4:10 PM AEST
Pro Medicus Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 146.48 | 107.49 | 60.06 | 91.25 | 63.66 |
Short-Term Investments | 105.79 | 103.17 | 95.36 | 30.25 | 26.9 |
Cash & Short-Term Investments | 252.28 | 210.66 | 155.43 | 121.5 | 90.55 |
Cash Growth | 19.76% | 35.53% | 27.93% | 34.17% | 46.49% |
Accounts Receivable | 97.55 | 64.07 | 48.14 | 39.84 | 27.18 |
Other Receivables | 2.8 | 0.37 | 0.15 | 0.23 | 0.26 |
Receivables | 100.35 | 64.44 | 48.28 | 40.08 | 27.44 |
Inventory | - | - | 0.05 | 0.06 | 0.08 |
Prepaid Expenses | 3.47 | 3.97 | 1.89 | 1.58 | 1.3 |
Other Current Assets | 1.87 | 1.03 | 0.92 | 0.59 | 0.45 |
Total Current Assets | 357.97 | 280.09 | 206.56 | 163.79 | 119.82 |
Property, Plant & Equipment | 2.79 | 2.77 | 2.38 | 2.19 | 2.6 |
Long-Term Investments | 189.36 | 7.34 | 7.34 | - | - |
Other Intangible Assets | 22.08 | 20.77 | 20.07 | 21.35 | 22.29 |
Long-Term Deferred Tax Assets | 28.25 | 23.8 | 17.18 | 12.21 | 10.87 |
Long-Term Deferred Charges | 9.41 | 3.89 | 3.86 | 2.36 | 1.47 |
Other Long-Term Assets | 0.29 | 0.05 | 0.04 | 0.24 | - |
Total Assets | 610.14 | 338.7 | 257.43 | 202.14 | 157.05 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.09 | 1.41 | 1.74 | 1.03 | 1.64 |
Accrued Expenses | 6.71 | 6.12 | 4.35 | 3.75 | 2.98 |
Current Portion of Leases | 0.77 | 0.66 | 0.55 | 0.65 | 0.6 |
Current Income Taxes Payable | 7.38 | 4.1 | 2.4 | 6.54 | 6.3 |
Current Unearned Revenue | 22.63 | 19.11 | 17.05 | 12.6 | 10.13 |
Other Current Liabilities | 13.66 | 11.75 | 8.46 | 6.27 | 5.21 |
Total Current Liabilities | 52.25 | 43.14 | 34.56 | 30.85 | 26.86 |
Long-Term Leases | 1.46 | 1.6 | 1.52 | 1.2 | 1.68 |
Long-Term Unearned Revenue | 42.71 | 29.43 | 25.85 | 23.42 | 18.63 |
Long-Term Deferred Tax Liabilities | 62.74 | 7.51 | 7.66 | 7.81 | 8.09 |
Other Long-Term Liabilities | 0.07 | 0.06 | 0.11 | 0.08 | 0.07 |
Total Liabilities | 159.22 | 81.74 | 69.7 | 63.36 | 55.32 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 49.6 | 34.73 | 23.65 | 1.96 | 1.96 |
Retained Earnings | 440.02 | 239.46 | 173.36 | 127.12 | 92.58 |
Treasury Stock | -26.54 | -16.4 | -8.54 | -5.77 | -5.22 |
Comprehensive Income & Other | -12.17 | -0.84 | -0.73 | 15.48 | 12.42 |
Shareholders' Equity | 450.92 | 256.96 | 187.73 | 138.78 | 101.73 |
Total Liabilities & Equity | 610.14 | 338.7 | 257.43 | 202.14 | 157.05 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 2.23 | 2.26 | 2.07 | 1.85 | 2.28 |
Net Cash (Debt) | 250.05 | 208.4 | 153.36 | 119.64 | 88.28 |
Net Cash Growth | 19.98% | 35.89% | 28.18% | 35.54% | 49.12% |
Net Cash Per Share | 2.39 | 1.99 | 1.47 | 1.14 | 0.84 |
Filing Date Shares Outstanding | 104.47 | 104.46 | 104.42 | 104.43 | 104.28 |
Total Common Shares Outstanding | 104.47 | 104.46 | 104.42 | 104.43 | 104.28 |
Working Capital | 305.72 | 236.96 | 172.01 | 132.94 | 92.96 |
Book Value Per Share | 4.32 | 2.46 | 1.80 | 1.33 | 0.98 |
Tangible Book Value | 428.83 | 236.2 | 167.66 | 117.43 | 79.44 |
Tangible Book Value Per Share | 4.10 | 2.26 | 1.61 | 1.12 | 0.76 |
Machinery | - | - | - | - | 3.07 |